The clinical implications of these findings are significant as ischemic disease is a major burden in the health care system and the deleterious effects of ischemia could be ameliorated by inducing angiogenesis in the ischemic tissue using ASCs with potentiated VEGF secretion. This evidence concerns the gene VEGFA and ischemic disease.